DI
Diaceutics PLC
DIUXF · OTC
$2.31 +0.00% (+$0.00)
Market Cap £147.5M
P/E Ratio 1,521.07x
Div. Yield -
ROE 0.25%
Bulios Fair Price
$1.85
19.8% downside
Current Price
$2.31
Undervalued Fair Value Overvalued
According to Bulios Fair Price, DIUXF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
12 /100
Expensive P/E 1,521.07x
EV/EBITDA 25.24x
P/S 3.84x
Growth
62 /100
Stable EPS growth 49.22%
Rev. growth 25.37%
FCF growth 72.41%
Profitability
30 /100
Weak Gross margin 66.78%
Net margin 0.25%
Op. margin 0.55%
Quality
11 /100
Poor ROIC 0.16%
ROE 0.25%
ROA 0.19%
Debt
80 /100
Low Debt/Equity 0.03x
Current ratio 3.43x
Int. coverage -3.66x
Stability
57 /100
Moderate Beta 0.89x
Rev. volatility 8.82%
EPS volatility 236.82%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DIUXF
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Ryan Keeling
Employees
205
Headquarters
Belfast